Health Catalyst plummets after mixed Q4; CEO declines to rule out potential sale as part of review
Source: SeekingAlpha
2026-03-13 11:24:36 ET
More on Health Catalyst
- Health Catalyst refrains from 2026 annual guidance as new CEO launches operational overhaul and strategic review
- Health Catalyst Q4 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Health Catalyst
- Historical earnings data for Health Catalyst
Read the full article on Seeking Alpha
For further details see:
Health Catalyst plummets after mixed Q4; CEO declines to rule out potential sale as part of review
Health Catalyst Inc
NASDAQ: HCAT
HCAT Trading
-22.35% G/L:
$1.39 Last:
1,860,868 Volume:
$1.38 Open:
HCAT Latest News
HCAT Stock Data
$146,412,930
68,891,881
0.25%
50
N/A
Healthcare Providers & Services
Healthcare
US
South Jordan
